MSFT
Microsoft Corporation
MSFT has the edge over TACT overall, supported by stronger valuation and stronger modeled upside.
TACT
TransAct Technologies Incorporated
TACT trails on the overall score without a compensating advantage in the available component scores.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
TACT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
TACT's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
TACT PE Valuation
TACT has no meaningful PE right now: it lost money over the past year.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
MSFT has the edge over TACT on the outlook, with more favorable earnings and profitability expectations.
TACT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect TACT's losses to grow, with revenue growing.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over TACT on earnings quality, reporting a profit while its opponent remains loss making.
TACT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.04 | +$0.82 |
| Q1 2026 | -$0.05 | +$0.83 |
| Q4 2025 | -$0.12 | +$0.86 |
| Q3 2025 | -$0.80 | -$0.60 |
| Q2 2025 | -$0.86 | -$0.81 |
| Q1 2025 | -$0.88 | -1567% |
| Q4 2024 | -$0.98 | -309% |
| Q3 2024 | -$0.20 | -139% |
TACT is still losing money, but far less than before: $0.04 per share over the past year, against $0.98 at its worst in late 2024.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over TACT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over TACT on profitability, with a higher operating margin.
TACT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.9M | +1.1% |
| Q1 2026 | $14.4M | +10% |
| Q4 2025 | $11.5M | +12% |
| Q3 2025 | $13.2M | +21% |
| Q2 2025 | $13.8M | +19% |
| Q1 2025 | $13.1M | +22% |
| Q4 2024 | $10.2M | -23% |
| Q3 2024 | $10.9M | -37% |
TACT's revenue has grown year over year for six quarters in a row: $14M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -0.4% | +1.5 points |
| Q1 2026 | 5.3% | +5.5 points |
| Q4 2025 | -10% | +0.2 points |
| Q3 2025 | 0.1% | +7.8 points |
| Q2 2025 | -1.9% | +1.9 points |
| Q1 2025 | -0.1% | +12 points |
| Q4 2024 | -10% | -6.3 points |
| Q3 2024 | -7.7% | -15 points |
TACT's operating margin was −0.4% last quarter, up 1.5 points from the same quarter a year ago.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
TACT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.1M | -41% |
| Q1 2026 | -$1M | -$855K |
| Q4 2025 | $589K | -75% |
| Q3 2025 | $3.6M | +1278% |
| Q2 2025 | $3.6M | +617% |
| Q1 2025 | -$171K | +$1.4M |
| Q4 2024 | $2.4M | +196% |
| Q3 2024 | $259K | -68% |
TACT has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over TACT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
TACT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +56K shares |
| 1 year | +2% | +204K shares |
| 3 years | +2.7% | +272K shares |
| 5 years | +15% | +1.3M shares |
| Available history | +33% | +2.5M shares |
TACT has 10M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q3 2019 | — |
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
TACT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -82.4x | Net Cash |
| Q1 2026 | -565.8x | Net Cash |
| Q2 2024 | -26.7x | Net Cash |
| Q1 2024 | -4.0x | Net Cash |
| Q4 2023 | -1.4x | Net Cash |
| Q3 2023 | -1.1x | Net Cash |
| Q2 2023 | -1.2x | Net Cash |
| Q1 2023 | -1.4x | Net Cash |
TACT has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
TACT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.1 | Neutral |
| Stochastic | 47.5 | Neutral |
TACT's weekly RSI is 51 (neutral) and its Stochastic is 48 (neutral).
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
TACT PE vs Technology Sector
| Metric | TACT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
TACT has no meaningful PE right now: it lost money over the past year.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over TACT on trend strength, trading above more of its moving averages.
TACT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.88 | 0% above |
| 20 week MA | $5.05 | 3.4% below |
| 50 week MA | $4.35 | 12% above |
| 100 week MA | $4.23 | 15% above |
| 200 week MA | $5.10 | 4.3% below |
TACT's trend is mixed: it's above two of its five weekly moving averages, and 4.3% below its 200-week average.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.
TACT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.7 | $7.37 | -31% |
| 2021 | $7.37 | $10.6 | +44% |
| 2022 | $10.6 | $6.18 | -42% |
| 2023 | $6.18 | $6.98 | +13% |
| 2024 | $6.98 | $4.14 | -41% |
| 2025 | $4.14 | $3.92 | -5.3% |
| 2026 YTD | $3.92 | $4.88 | +24% |
TACT has the edge over MSFT on returns for 2026, with the stronger performance.